Dr. George A Karpouzas, MD
Claim this profileThe Lundquist Institute at Harbor-UCLA Medical Center
Studies Systemic Lupus Erythematosus
Studies Lupus
6 reported clinical trials
19 drugs studied
Affiliated Hospitals
Clinical Trials George A Karpouzas, MD is currently running
M5049
for Lupus
This trial involves taking a pill called M5049. It targets patients with specific types of lupus who have already been treated for several months. The goal is to check if the pill is safe and works well over a longer time.
Recruiting0 awards Phase 22 criteria
Zetomipzomib
for Lupus Nephritis
This trial is testing whether injections of zetomipzomib can help reduce kidney problems in people with lupus nephritis. The study includes patients who have active kidney inflammation due to lupus and are already receiving other treatments. Zetomipzomib works by calming the immune system to prevent further kidney damage.
Recruiting0 awards Phase 26 criteria
More about George A Karpouzas, MD
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments George A Karpouzas, MD has experience with
- Placebo
- BMS-986165
- Zetomipzomib
- Placebo
- GSK3196165 (Otilimab)
- Tofacitinib
Breakdown of trials George A Karpouzas, MD has run
Systemic Lupus Erythematosus
Arthritis
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
- Multidisciplinary Care for Rheumatoid Arthritis
Rheumatoid Arthritis
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
- Multidisciplinary Care for Rheumatoid Arthritis
Nephritis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does George A Karpouzas, MD specialize in?
George A Karpouzas, MD focuses on Systemic Lupus Erythematosus and Lupus. In particular, much of their work with Systemic Lupus Erythematosus has involved treating patients, or patients who are undergoing treatment.
Is George A Karpouzas, MD currently recruiting for clinical trials?
Yes, George A Karpouzas, MD is currently recruiting for 2 clinical trials in Torrance California. If you're interested in participating, you should apply.
Are there any treatments that George A Karpouzas, MD has studied deeply?
Yes, George A Karpouzas, MD has studied treatments such as Placebo, BMS-986165, zetomipzomib.
What is the best way to schedule an appointment with George A Karpouzas, MD?
Apply for one of the trials that George A Karpouzas, MD is conducting.
What is the office address of George A Karpouzas, MD?
The office of George A Karpouzas, MD is located at: The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California 90502 United States. This is the address for their practice at the The Lundquist Institute at Harbor-UCLA Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.